Urine Tx-M and PGI-M concentrations in ADAT participants categorized by treatment adherence, group assignment, and aspirin use.

Two-way ANOVAs were performed for each eicosanoid in compliant and non-compliant subjects for the three treatment groups. Group assignment was significantly (+P∧P>0.05). ASA use was associated with reduced urine Tx-M concentrations (#P#P0.05. In addition, values for ASA compliant and noncompliant individuals were calculated regardless of treatment group assignment, presented in rows labeled subtotal, and compared using t-tests (++P